HLTH Stock — Cue Health Inc.: Metrics

Market overview

2 metrics

Share price

$28.50

Market cap

$4.51B

Price action

19 metrics

Price change (1W)

-5.6%

Price change (30D)

+9.2%

Price change (3M)

—

Price change (6M)

—

Price change (YTD)

—

Price change (1Y)

—

Trailing year

Price change (5Y)

—

52-week high

—

52-week low

—

Change from 52-week high

—

Change from 52-week low

—

Annualized volatility

—

Beta

—

RSI (14D)

55.1

Price vs SMA 50

—

Price vs SMA 200

—

Avg volume (3M)

12,258

Relative volume

0.3

Average dollar volume

$344,050

Company

3 metrics

Sector

—

Industry

—

Shares outstanding

158.52M

Valuation

12 metrics

P / E (TTM)

—

Trailing earnings

PEG ratio

—

EV / revenue

—

EV / EBITDA

—

EV / EBIT

—

P / sales

63.6×

reciprocal yield 1.6%

P / book

18.0

reciprocal yield 5.6%

FCF yield

-3.3%

TTM · current market cap

Buyback yield

—

P / FCF

—

P / operating cash flow

—

Earnings yield

-8.3%

Historical valuation

8 metrics

P / E historical average (3Y)

—

P / E historical average (5Y)

—

EV / revenue historical average (3Y)

—

EV / revenue historical average (5Y)

—

EV / EBIT historical average (3Y)

—

EV / EBIT historical average (5Y)

—

EV / EBITDA historical average (3Y)

—

EV / EBITDA historical average (5Y)

—

Dividends & buybacks

7 metrics

Dividend yield

—

Trailing 12 months

Payout ratio

—

Shareholder yield

—

Dividend / share (TTM)

—

Dividend growth YoY

—

Dividend growth streak

—

Last ex-dividend

—

Earnings calendar

2 metrics

Next earnings

—

Last earnings

2024-03-13

Profitability

9 metrics

Gross margin

—

Operating margin

-556.6%

Trailing 12 months

Net margin

-526.5%

Gross profit (TTM)

—

Operating profit (TTM)

−$394.85M

Net income (TTM)

−$373.46M

Trailing 12 months

Diluted EPS (TTM)

$-2.44

FCF margin

-207.2%

Effective tax rate

—

Per share

11 metrics

Revenue per diluted share (TTM)

—

Gross profit per diluted share (TTM)

—

Operating profit per diluted share (TTM)

—

EBITDA per diluted share (TTM)

—

Net income per diluted share (TTM)

—

Operating cash flow per diluted share (TTM)

—

Free cash flow per diluted share (TTM)

—

Capital expenditures per diluted share (TTM)

—

R&D per diluted share (TTM)

—

Stock compensation per diluted share (TTM)

—

Book value per share

$-3.62

Growth

11 metrics

Revenue growth YoY

-87.2%

Year over year

Net income growth YoY

—

Revenue (TTM)

$70.94M

Trailing 12 months

EPS growth YoY

—

Shares change YoY

+3.4%

Year over year · more shares

Revenue CAGR (3Y)

+45.7%

Revenue CAGR (5Y)

—

EPS CAGR (3Y)

—

EPS CAGR (5Y)

—

FCF CAGR (3Y)

—

FCF CAGR (5Y)

—

Quality

14 metrics

Return on equity

-149.2%

Return on assets

-109.9%

Debt / equity

—

Current ratio

2.5

EBITDA (TTM)

−$338.57M

Free cash flow (TTM)

−$146.98M

Quick ratio

2.2

Interest coverage

—

Net debt / EBITDA

—

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Cash & equivalents

$80.89M

Total assets

$339.79M

Total debt

$0

Cash flow & spend

7 metrics

Operating cash flow (TTM)

−$137.81M

Capital expenditures (TTM)

$9.17M

R&D (TTM)

$150.62M

SG&A (TTM)

—

Stock compensation (TTM)

$48.73M

R&D / revenue

212.3%

Stock compensation / revenue

68.7%

Ownership (13F)

3 metrics

13F filers

—

13F filer change QoQ

—

Institutional ownership

—

Short interest

3 metrics

Short interest

0.0%

Latest settlement · 1.0 days to cover

Days to cover

1.0d

Short-squeeze score

33 / 100

Insider activity

2 metrics

Net insider buying (90D)

—

Insider-sentiment score

—

Risk flags

1 metrics

Going concern

—

HLTH · Cue Health Inc.

HLTH metrics

Market overview

Price action

Company

Valuation

Historical valuation

Dividends & buybacks

Earnings calendar

Profitability

Growth

Quality

Cash flow & spend

Ownership (13F)

Short interest

Insider activity

Risk flags

No metrics match that search